One of these liminal examples of germline editing involves the gene PCSK9, which produces a protein that regulates a person’s level of low-density lipoprotein cholesterol (the “bad” cholesterol), making the gene one of the most promising pharmaceutical targets to prevent heart disease—the leading cause of death worldwide.
